Biovotec Obtains Additional Funding And Recognition

CEO Ralf Schmidt raised another 15 million NOK in new capital and now he is asked to present Biovotec to the British health authorities.


Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Engebrets vei 3, 0275 Oslo, Norway                                                   © Biovotec AS                                                                       info@biovotec